| __timestamp | Iovance Biotherapeutics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 117418000 |
| Thursday, January 1, 2015 | 999000 | 102526000 |
| Friday, January 1, 2016 | 978000 | 105386000 |
| Sunday, January 1, 2017 | 952000 | 110188000 |
| Monday, January 1, 2018 | 956000 | 121544000 |
| Tuesday, January 1, 2019 | 8122999 | 127930000 |
| Wednesday, January 1, 2020 | 8712000 | 148917000 |
| Friday, January 1, 2021 | 13980000 | 440760000 |
| Saturday, January 1, 2022 | 21135000 | 540517000 |
| Sunday, January 1, 2023 | 10755000 | 435577000 |
Cracking the code
In the dynamic world of biopharmaceuticals, understanding cost structures is crucial for investors and stakeholders. Jazz Pharmaceuticals plc and Iovance Biotherapeutics, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Jazz Pharmaceuticals, a leader in the field, has seen its cost of revenue grow by nearly 270% over this period, peaking in 2022. This reflects its aggressive expansion and investment in new therapies. In contrast, Iovance Biotherapeutics, a company focused on innovative cancer treatments, experienced a more volatile trend, with a significant spike in 2022, marking a 120% increase from 2020. This fluctuation highlights the challenges and opportunities in pioneering new treatments. As the biopharma landscape evolves, these trends offer valuable insights into the strategic directions of these companies, underscoring the importance of cost management in sustaining growth and innovation.
Novo Nordisk A/S vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down AbbVie Inc. and Jazz Pharmaceuticals plc's Expenses
Cost of Revenue Comparison: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Vericel Corporation
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Galapagos NV
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Iovance Biotherapeutics, Inc.
Corcept Therapeutics Incorporated vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Iovance Biotherapeutics, Inc.